TENX
TENAX THERAPEUTICS, INC.
+0.02 (+1.37%)1.85USD2.3M成交股數69.0M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 0.00 | – | – | – | 0.00 | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.9M | 11.5M | 10.5M | 10.3M | 6.1M | 5.7M | 3.1M | 2.3M | 2.7M | 1.7M | 1.1M | 198K |
| 銷售管理費用 | 5.9M | 5.0M | 5.9M | 6.5M | 5.7M | 5.7M | 1.5M | 1.3M | 1.2M | 1.6M | 1.1M | 1.0M |
| 營業利益 | −18.8M+59% | −16.6M+46% | −16.4M+256% | −16.8M+358% | −11.8M+202% | −11.3M+13% | −4.6M-318% | −3.7M-397% | −3.9M | −10.0M | 2.1M | 1.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −17.8M+64% | −15.7M+51% | −15.5M+292% | −15.8M+342% | −10.8M+186% | −10.4M+45% | −4.0M-301% | −3.6M+223% | −3.8M | −7.2M | 2.0M | −1.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.35+30% | -0.35+25% | -0.39+105% | -0.40-78% | -0.27-91% | -0.28 | -0.19 | -1.83 | -3.12 | – | – | – |
| 稀釋股數 | 50.9M | 45.2M | 39.2M | 39.7M | 39.6M | 36.6M | 21.2M | 2.0M | 1.2M | 248K | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 118M | 119M | 97.6M | 99.4M | 106M | 111M | 98.3M | 9.4M | 12.5M | 9.8M | 11.1M | 13.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 122M | 123M | 104M | 103M | 106M | 112M | 99.8M | 10.6M | 14.5M | 11.7M | 11.9M | 14.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 8.1M | 8.5M | 7.2M | 6.6M | 2.5M | 2.8M | 2.6M | 1.7M | 2.0M | 3.6M | 602K | 824K |
| 股東權益 | 114M | 115M | 97.1M | 96.2M | 103M | 109M | 97.2M | 8.9M | 12.4M | 8.1M | 11.3M | 13.2M |
| 負債比 | 6.6% | 6.9% | 6.9% | 6.4% | 2.4% | 2.5% | 2.6% | 16.4% | 14.0% | 30.7% | 5.1% | 5.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.3M+34% | – | – | – | −7.0M | – | – | −5.2M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 0.00 | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −52.6M | –% | -1.34 | – |
| FY2024 | 0.00 | – | −17.6M | –% | -1.15 | – |
| FY2023 | – | – | −7.7M | –% | -31.04 | – |
| FY2022 | – | – | 11.0M | –% | – | −11.4M |
| FY2021 | 949.00 | -41.7% | −32.5M | -3,421,955.5% | -1.58 | −10.9M |
| FY2020 | 2K | – | −9.9M | -605,494.2% | -0.95 | −9.3M |
| FY2019 | – | – | −8.4M | –% | -1.35 | −7.6M |
| FY2018 | – | – | −14.1M | –% | -9.04 | −5.5M |